Role of the sigma-1 receptor chaperone in rod and cone photoreceptor degenerations in a mouse model of retinitis pigmentosa
- Huan Yang†1,
- Yingmei Fu†1, 2,
- Xinying Liu3,
- Pawan K. Shahi3,
- Timur A. Mavlyutov4,
- Jun Li1, 5, 6,
- Annie Yao1,
- Steven Z.-W. Guo1,
- Bikash R. Pattnaik3, 7Email author and
- Lian-Wang Guo1, 7, 8Email author
© The Author(s). 2017
Received: 26 February 2017
Accepted: 9 August 2017
Published: 19 September 2017
Retinitis pigmentosa (RP) is the most common inherited retinal degenerative disease yet with no effective treatment available. The sigma-1 receptor (S1R), a ligand-regulated chaperone, emerges as a potential retina-protective therapeutic target. In particular, pharmacological activation of S1R was recently shown to rescue cones in the rd10 mouse, a rod Pde6b mutant that recapitulates the RP pathology of autonomous rod degeneration followed by secondary death of cones. The mechanisms underlying the S1R protection for cones are not understood in detail.
By rearing rd10/S1R−/− and rd10/S1R+/+ mice in dim light to decelerate rapid rod/cone degeneration, we were able to compare their retinal biochemistry, histology and functions throughout postnatal 3–6 weeks (3 W–6 W).
The receptor-interacting protein kinases (RIP1/RIP3) and their interaction (proximity ligation) dramatically up-regulated after 5 W in rd10/S1R−/− (versus rd10/S1R+/+) retinas, indicative of intensified necroptosis activation, which was accompanied by exacerbated loss of cones. Greater rod loss in rd10/S1R−/− versus rd10/S1R+/+ retinas was evidenced by more cleaved Caspase3 (4 W) and lower rod electro-retinographic a-waves (4 W–6 W), concomitant with reduced LC3-II and CHOP (4 W–6 W), markers of autophagy and endoplasmic reticulum stress response, respectively. However, the opposite occurred at 3 W.
This study reveals previously uncharacterized S1R-associated mechanisms during rd10 photoreceptor degeneration, including S1R’s influences on necroptosis and autophagy as well as its biphasic role in rod degeneration upstream of cone death.
The sigma-1 receptor (S1R) is a molecular chaperone that modulates a variety of cellular activities. While ubiquitously distributed, it is abundant in the central and peripheral nervous systems . The S1R binding site is the target of numerous pharmacological studies on psychotic disorders , locomotor activity , threat response , and pain  etc. Many S1R-binding compounds have been identified ; some are in clinical use (e.g., as antidepressants)  or trials . A protective role of S1R has been increasingly reported in neurodegenerative disease models , including Parkinson’s , Alzheimer’s , Huntington’s  and ALS . Furthermore, human S1R mutations were linked to ALS  and frontotemporal lobar degeneration . Abnormal S1R subcellular localization was found in postmortem brain samples of neurodegenerative diseases . Thus, S1R appears to be a potential anti-neurodegenerative therapeutic target. The recently solved S1R crystal structure  is expected to accelerate therapeutic development of S1R drugs.
Degeneration of retinal neurons, mainly photoreceptors (PRs, i.e., rods and cones) and retinal ganglion cells (RGCs), shares considerable patho-mechanisms with neurodegenerative brain diseases. An important recent development is that S1R was found to protect RGCs (for review, see [17, 18]), in RGC-damage mouse models either treated with S1R agonists [19, 20] or compared between wild type and S1R knockout (S1R−/−) [21, 22]. Wang et al.  just reported that intraperitoneal repeat injections of S1R agonist (+)-pentazocine substantially rescued cones in the rd10 mouse model (rod Pde6b mutation) of retinitis pigmentosa (RP). RP is a heterogeneous group of inherited retinal degenerations linked to thousands of mutations in over 70 human genes . The rd10 model exemplifies RP with autonomous rod degeneration and secondary cone death . As it is not yet practical to correct RP mutations individually, investigation of a common pathway, e.g., S1R, a target suitable for pharmacological interventions , is highly significant. It is therefore imperative to understand how S1R influences PR death in rd10 mice.
A recent report distinguishes that apoptosis and necroptosis (programed necrosis) are chief mechanisms responsible for the sequential death of rods and cones, respectively . While apoptosis has been well-documented, necroptosis of cones is a relatively new mechanism not well understood in rd10 retinas. In particular, whether S1R influences this process is not known. Moreover, since cone death results from dying rods in rd10 retinas , it is important to understand whether the S1R protection against cone death at later stages involves its influence on rod degeneration at earlier stages. However, the specific role(s) of S1R in rod degeneration remains unclear, presumably because the previous study primarily focused on cone death , a stage when rod function was barely detectable.
To investigate the specific role(s) of S1R at different stages of rd10 PR degeneration, we designed a unique experimental setting with the following considerations. First, we crossed rd10 to S1R knockout mice  and used this S1R-null strain (rd10/S1R−/−) throughout to compare with rd10 mice (rd10/S1R+/+). Second, we reared these mice in dim red light (< 5 lx) instead of regular housing light to retard aggressive rd10 PR degeneration, so that we were able to improve the “temporal resolution” of our data. Third, we studied the impact of S1R knockout on the activation of necroptosis, the mode of cone death . Fourth, we determined the time course including early time points to define the role of S1R in rod degeneration that precedes cone death. We observed a dramatic increase of necroptosis activation in rd10/S1R−/− retinas compared to rd10/S1R+/+ retinas, and also made a surprising finding that in early stage rods were protected without S1R. The underlying mechanisms are discussed.
Animal ethics statement
All animal procedures conformed to the NIH guide for the ethical care and use of laboratory animals and were in compliance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. Animal protocols were approved by the Institutional Animal Care and Use Committee of University of Wisconsin-Madison and Ohio State University. All surgeries were performed under isoflurane anesthesia. Animals were maintained on a 4% fat diet (8604 M/R, Harkland Teklad, Madison, WI), and euthanized in a chamber gradually filled with CO2.
Mouse strains, breeding, and rearing
A homozygous rd10 mouse breeding pair (B6.CXB1-Pde6b rd10 /J, stock number 004297) were purchased from the Jackson Laboratory (Bar Harbor, ME). This model of retinitis pigmentosa (RP) is a spontaneous missense point mutation in Pde6b (rod-specific cGMP phosphodiesterase 6 beta subunit) . Progressive rod (and then cone) photoreceptor degeneration in homozygous rd10 mice begins at postnatal day 16 and completes at day 35.
A breeding pair of heterozygous S1R knockout mice, which are Oprs1 mutant (+/−) OprsGt(IRESBetageo)33Lex on a C57BL/6 J × 129 s/SvEv mixed background, were purchased from the Mutant Mouse Regional Resource Center (UC Davis, CA). The colony of homozygous S1R knockout mice (S1R−/−) was established after back-crossing to C57BL/6 J mice for nine times to reach a relatively uniform background. The S1R−/− mice were then crossed with rd10 mice to generate an rd10/S1R−/− strain. Litter mates of rd10/S1R−/− and rd10/S1R+/+ mice were confirmed by genotyping (see below) and then used for experiments. In order to slow down photoreceptor degeneration thus enlarging the window of experimental time course, these mice were reared in a dedicated room equipped with dim (<5 lx) red light (12 h/12 h light/dark). The rearing conditions were otherwise standard.
Homozygous Nrl-GFP mice, or B6.Cg-Tg(Nrl-EGFP)1Asw/J (stock number 021232), were purchased from the Jackson Laboratory (Bar Harbor, ME). In this transgenic strain, the Nrl (neural retina leucine zipper gene) promoter drives expression of EGFP specifically in rod photoreceptors and the pineal gland. In the adult retina, GFP is detected only in the outer nuclear layer, which contains rod and cone photoreceptor nuclei, and in the corresponding rod inner and outer segments.
Genotyping of rd10/S1R−/− and rd10/S1R+/+ mice
For S1R genotyping, primers 5′-tctgagtacgtgctgctcttcg (985–5′), 5′-cagaaatctcagcccagtatcg (985–3′) and 5′-ataaaccctcttgcagttgcatc (LTR-rev) were synthesized. The pair of 985–5′ and 985–3′ were used to amplify the Sigmar1 wildtype allele (~200 bp PCR products), and the pair of 985–5′ and LTR-rev were used to identify the Sigmar1 knockout allele (~400 bp PCR products) . To genotype rd10, primers 5′-ctttctattcctctgtcagcaagc (Pde6b13F) and 5′-catgagtagggtaaacatggtctg (Pde6b13R) were used . After PCR amplification, products (97 bp) were subjected to 2 ~ 5 units of CfoI (Promega) digestion for 2 h at 37 °C. While the non-cleavable Pde6b wildtype products showed a size of 97 bp, the Pde6b rd10 mutant products were processed into fragments of 54 bp and 43 bp.
Preparation of retinal sections and homogenates
In this study, the majority of experiments were performed for a time course spanning from postnatal 3 weeks (3 W) to 6 W. Mice were euthanized by CO2 asphyxiation followed by cervical dislocation at 3 W, 4 W, 5 W, and 6 W. Eyeballs were enucleated immediately and dissected. For morphometric and immunohistochemistry analyses, retinal cryosections were prepared according to our published methods [21, 27]. Briefly, eyeballs were fixed in 4% paraformaldehyde for 7 h at 4 °C and then soaked in 30% sucrose in PBS for 14 h at 4 °C, and 10 μm sections were cut from the eyeballs frozen in optimum cutting temperature (OCT) embedding medium (Sakura Finetek USA, Inc., Torrance, CA). For Western blotting, unfixed eyeballs were used. The cornea was removed, and the retina was carefully dissected out of the eyecup. Caution was taken to avoid contamination of the retinal pigment epithelium (RPE). Retinas were homogenized and immediately used for protein separation on a polyacrylamide gel followed by immunoblotting .
Immunohistochemistry and fluorescence microscopy
Immunostaining was performed on retinal cryosections following our previously described method  with minor modifications. Briefly, retinal sections were permeabilized with 0.1% Triton X-100 in PBS for 20 min, blocked with 5% normal donkey serum (017–000-121; Jackson Immunoresearch Lab, MS) for 1 h at room temperature, and then incubated with a primary antibody overnight at 4 °C. Sources and dilutions of primary antibodies are the following: Anti-ACTIVE® Caspase-3 pAb (Promega, G7481), 1:250, Rabbit anti-IBA-1 (Wako, 019–19,741), 1:100; Rabbit anti-GFAP (Cell Signaling, 12,389), 1:100; rabbit anti-S1R (in-house produced), 1:50; Mouse anti-BRN3A (Millipore, AB5945), 1:100. After rinsing the section 3×, a secondary antibody (Alexa-488 conjugated donkey-anti-rabbit or Alexa-555-conjugated donkey-anti-mouse) at 1 μg/ml was applied at room temperature for 1 h. Sections stained with a secondary antibody, but not a primary antibody, were used for negative control. Sections were then rinsed 3×, counterstained with Hoechst 33,342 (Life Technologies, H3570) at 5 μg/ml for 1 min, and then mounted in Prolong Gold mounting medium (Invitrogen, Carlsbad, CA) and cover-slipped. The slides were left in the dark overnight and then sealed using clear nail polish (Electron Microscopy Sciences, Hatfield, PA). To visualize cones, retinal sections were incubated with Fluorescein-labeled Peanut Agglutinin (PNA, Vector Laboratories, FL-1071, 1:500 dilution) for 1 h at room temperature and then washed. Images were acquired under a 60X oil objective lens with a Nikon A1RS confocal microscope. Immuno-fluorescence from central and mid-peripheral regions was quantified using ImageJ.
Proximity ligation assay to detect RIP1/RIP3 interaction
Proximity ligation assay was performed following our published method , using the Duolink® In Situ Red Starter Kit (Mouse/ Rabbit), which was purchased from Sigma-Aldrich (DUO92101). Cryosections were blocked with 5% normal donkey serum in PBS containing 0.1 Triton-X 100 for 1 h at room temperature. Mouse anti-RIP1 (BD Transduction Laboratories, 610,459, 1:100) and Rabbit anti-RIP3 (ProSci, 2283, 1:100) were then incubated with the sections overnight. PLA® probes incubation, ligation, amplification, and mounting followed manufacturer’s instructions. Images were taken and analyzed using a Nikon A1RS confocal microscope.
Tyramide signal amplification (TSA)-enhanced immunostaining to detect cleaved-Caspase3
TSA enhanced immunostaining has been described previously . Briefly, retinal sections were first incubated with 1% H2O2 for 1 h at room temperature to quench endogenous peroxidase, then blocked with 5% BSA, 0.1% Triton-X 100 in PBS for another hour at room temperature. Following incubation with rabbit anti-ACTIVE® Caspase-3 pAb (Promega, G7481, 1:250) and HRP-conjugated goat anti-rabbit secondary antibody (Jackson ImmunoReseach, 115–035-003, 1:1000), the sections were washed twice, 3 min each, in 100 mM borate (pH 8.5) supplemented with 0.1% Tween-20. The sections were then incubated with Tyramide-CF568 (Biotium, 92,173, 1 μg/ml) in TSA reaction buffer (100 mM borate, pH 8.5, 0.1% Tween-20, 0.003% H2O2) for 30 min at room temperature. After washing with PBS + 0.1% Tween-20, the sections were counterstained with Hoechst 33,342 prior to imaging with a Nikon A1RS confocal microscope.
Western blotting for assessment of protein levels
To compare protein levels between experimental conditions, two retinas were collected from one mouse of each condition, homogenized and then subjected to Western blotting. Thus, each lane on the blot represents two retinas of the same mouse of one experimental condition. The retina homogenization/Western blotting experiment was repeated 3 or 4 times each time with a different mouse of the same experimental condition (one lane, one condition). Normalized values (of the same condition) from 3 or 4 blots were averaged.
Retinal homogenates were prepared  and solubilized in RIPA buffer containing protease inhibitors (50 mM Tris, 150 mM NaCl, 1% Nonidet P-40, 0.1% sodium dodecyl sulfate, and 10 μg/ml aprotinin). Protein concentrations of cell lysates were determined using a Bio-Rad DC™ Protein Assay kit. Approximately 15–30 μg of proteins from each sample was separated on 4–20% Mini-PROTEAN TGX precast gels (Bio-Rad) and transferred to PVDF membranes. Sources and dilutions of primary antibodies are the following: Mouse anti-RIP1 (BD Transduction Laboratories, 610,459), 1:1000, Rabbit anti-RIP3 (ProSci, 2283), 1:1000, Cleaved Caspase3 (Asp175) (5A1E) Rabbit mAb (Cell Signaling, 9664), 1:1000, Rabbit anti-IBA-1 (Novus, NBP2–19019), 1:1000; Rabbit anti-GFAP (Cell Signaling, 12,389), 1:1000; rabbit anti-CHOP (Santa Cruz, sc8327), 1:100; Rabbit anti-LC3 (Sigma-Aldrich, L7543), 1:5000, and mouse anti-β-actin (Sigma-Aldrich, A2228), 1:10,000. After incubation with HRP-conjugated secondary antibodies (1:5000, goat anti-rabbit or mouse, Bio-Rad), specific protein bands on the blots were visualized by applying enhanced chemiluminescence reagents according to the manufacturer’s instructions (Pierce, Rockford, IL) and then recorded with a LAS-4000 Mini imager (GE, Piscataway, NJ). Band intensity was quantified using ImageJ.
Electroretinogram recording for rod photoreceptor function
ISCEV standard full-field flash ERG was performed using HMsERG system (OcuScience, Henderson, NV) following our published method . Mice were dark-adapted overnight and anesthetized with intraperitoneal ketamine (90 mg/kg) and xylazine (8 mg/kg) under dim-red illumination. After topical application of tropicamide (1%, Alcon) and phenylephrine (2.5%, Alcon) for pupillary dilation and proparacaine hydrochloride (0.5%, Alcon) for topical anesthesia, stainless steel subdermal needle electrodes were placed for ground (at the tail) and under individual eye lids as reference electrodes. Rodent 2.5 mm contact lens with silver-embedded thread electrode were placed on cornea of each eye using Goniovisc hypromellose 2.5% ophthalmic lubricant solution (HUB Pharmaceuticals, CA). Flash ERG recordings were obtained simultaneously from both eyes at increasing light intensities from 0.03 to 30 cd⋅s/m2 (saturating intensity in our reported studies ) under dark-adapted conditions. The stimulus interval between flashes varied from 20 s at the lowest stimulus strengths to 60 s at the highest ones. Two to 10 responses were averaged depending on flash intensity. ERG signals were sampled at 1 kHz and recorded with 0.3 Hz low-frequency and 300 Hz high-frequency cutoffs. Analysis of a-wave and b-wave amplitudes was performed using ERGView analytical software (OcuScience, Henderson, NV) that digitally filters out high-frequency oscillatory potential wavelets. The a-wave amplitude was measured from the baseline to the negative peak, and the b-wave was measured from the a-wave trough to the maximum positive peak and plotted using Origin.
Morphometric analyses of photoreceptor degeneration and ganglion cell numbers
Retinal cryosections were Hoechst-stained for counting photoreceptor numbers with two approaches in parallel, following our published method with minor modifications [20, 27]. Briefly, on each sagittal section, the regions of 0–1000 μm and 1000–2000 μm from the optic nerve head were designated as central and mid-peripheral, respectively. Four fields were chosen in the central and mid-peripheral regions of the outer nuclear layer flanking the optic nerve head. In each of the four fields, the ONL thickness (first approach) or nuclei number (second approach) were manually measured. The values from all 3–4 sections of the same animal were averaged, and the means from 3 to 4 animals were then averaged to calculate the mean and standard error (SE) for each group of animals. Using the same method, we counted and quantified the numbers of both RGCs (BRN3A-positive) and total cells (nuclei in the RGC layer).
For morphometric analyses, fluorescence micrographs of Hoechst-stained retinal sections, selection of fields in ONL or GCL, and ONL thickness measurement and nuclei counting were all performed by students blinded to experimental grouping information. All data are presented as mean ± SE (standard error) of at least three independent experiments. Statistical significance (set at P < 0.05) was assessed by two-tailed unpaired Student’s-t-test performed with GraphPad Prism.
Cone PR degeneration is exacerbated due to S1R knockout in rd10 mice
Activation of the RIP1/RIP3 pathway in rd10 retinas is accelerated due to S1R knockout
Caspase3 activation in rd10 PR cells is accelerated due to S1R knockout
Müller glial but not microglial activation in rd10 retinas is accelerated due to S1R knockout
Biphasic changes of ER stress response and autophagy in rd10 retinas in response to S1R knockout
Biphasic effect of S1R knockout in rd10 mice on rod PR electrophysiology
Biphasic effect of S1R knockout in rd10 mice on photoreceptor degeneration
S1R knockout increases RGCs at 3 W in rd10 retinas
RP is the most common group of inherited retinal degenerations affecting one in 3500–5000 individuals, but there are no effective treatments available . The S1R chaperone emerges as a potential intervention target shared in different types of retinal degenerations [19, 20, 22, 23]. Of particular interest, Wang et al. very recently reported that pharmacological activation of S1R rescues cones in the rd10 model of RP that is characteristic of sequential death of rods and cones . In our study, by comparing dim light-reared rd10/S1R−/− versus rd10/S1R+/+ mice during a time course spanning early and late stages of PR degeneration, we were able to determine “time-resolved” specific roles of S1R in rod and cone degenerations. We made two major new findings: 1) RIP-indicated activation of necroptosis, the recently identified chief mechanism of rd10 cone death , was amplified due to S1R knockout; 2) likely contributing to cone death, rod degeneration was exacerbated at later stages (4 W–6 W) due to S1R knockout, although paradoxically alleviated at an earlier stage (3 W). We further identified that autophagy and ER stress response may at least partially account for these outcomes.
The rd10 model first undergoes autonomous rod degeneration and then cone death triggered by dying rods . While Caspase-mediated apoptosis is known to be the major mode of rod death, mechanisms underlying cone death are less well understood. Recently, Murakami et al. demonstrated that RIP3-mediated necroptosis is the mechanism dominating cone death in rd10 mice yet with little impact on rods . Thus, apoptosis and necroptosis, two distinct modes of cell death, account for sequential loss of rd10 rods and cones, respectively . In a good agreement with their report, our data showed that in rd10 mice (rd10/S1R+/+), cleaved Caspase3 peaked at 5 W and diminished at 6 W whereas levels of RIP1/RIP3 proteins and their interaction did not rise until 6 W, the time point when cone loss was observed (Fig. 1). Inasmuch as cone loss adversely impacts daily living, Wang et al. made a very significant finding that injecting (+)-pentazocine to activate S1R markedly preserved cones in rd10 mice . Whether this protection of cones involves a S1R-specific effect on the RIP pathway of necroptosis remained unknown. Here we found that compared to rd10/S1R+/+ mice, increases of retinal RIP1 and RIP3 proteins as well as their interaction occurred earlier (at 5 W) and were substantially enhanced in rd10/S1R−/− mice. Considering that cone loss occurred later (at 6 W), these results suggest that intensified necroptosis activation in the absence of S1R is an important contributor to aggravated cone death.
S1R influences necroptosis activation possibly by multiple mechanisms. First, it is known that glial release of inflammatory cytokines (e.g., TNFα) and reactive oxygen species (ROS), a hallmark of reactive gliosis [24, 27], potently stimulates necroptosis in the retina [37, 38]. Consistently, our data show that in rd10 retinas without (versus with) S1R, GFAP-indicated macroglial activation was substantially elevated. Although both astrocytes and Müller cells express GFAP , it was the characteristic Müller cell radial morphology that showed a burst at 5 W and 6 W in rd10/S1R−/− retinas (Fig. 4, a and b), accompanied by a marked up-regulation of RIP1/RIP3 expression and interaction. It is worth noting that in our experimental setting, we did not observe a major difference in IBA1-indicated microglial activation between the rd10 retinas without and with S1R, and IBA1 expression remained largely stable during the 3 W–6 W time course. Taken together, Müller glia appear to be the main contributor to intensified gliosis and necroptosis activation in rd10/S1R−/− retinas. An alternative explanation might be that necroptotic cones and ROS production thereof triggered Müller cell activation. However, a surge of GFAP occurred ahead (at 5 W) of RIPs (at 6 W) in rd10/S1R−/− retinas, arguing for a probable sequence of Müller cell gliosis and then necroptosis stimulation. Second, the two types of S1R-associated stress-response activities [1, 34, 36], indicated by LC3-II and CHOP, declined over time in the absence of S1R and diminished at 6 W. Elimination of these activities is expected to result in elevation of necroptosis stimulants such as inflammatory cytokines and ROS. Third, S1R may directly regulate necroptosis in cones independent of reactive gliosis, although at present little evidence is available. Elucidation of this scenario, while beyond the scope of the current study, requires future experiments of conditional S1R knockout in rd10 cones. Fourth, given that in rd10 mice cones die as a secondary event triggered by dying rods , logically, aggravated rod death, for instance due to S1R knockout, should consequently exacerbate cone loss.
Therefore, how S1R influences rod degeneration in rd10 mice is an important question. It remained unclear likely because the previous study primarily focused on the peak time of cone death, at which point rod loss was almost complete . In our experiments using mice reared under dim light, good levels of a-waves and b-waves were preserved at 3 W and 4 W and residual signals were still detectable at 5 W and 6 W in rd10/S1R+/+ mice. In comparison, a-wave and b-wave amplitudes were reduced at 4 W–6 W in rd10/S1R−/− mice (Fig. 6, b and d). Consistently, ONL thickness and nuclei numbers followed the same trend. Thus, our data support a protective role of S1R for rods in rd10 retinas during 4 W–6 W. Further supporting this assertion, S1R knockout in rd10 mice accelerated Caspase3-associated apoptosis, the known chief mechanism of rod death. In addition, in the Wang et al. report , injection of S1R agonist (+)-pentazocine started at 2 W and continued to 6 W, spanning the course of rod degeneration, and may have reduced cone death by ameliorating rod degeneration. Moreover, tracing rods by Nrl-driven GFP expression in the mouse retina, we verified the presence of S1R in rods via S1R immunopositivity.
The slow degeneration of RGCs in rd10 retinas observed here likely resulted from collateral damage inflicted by dying PR cells, as evidenced by detections positive for cleaved Caspase3 and RIP1/RIP3 ligation. The lack of difference in RGC numbers between rd10/S1R−/− and rd10/S1R+/+ retinas also informs that RGC death is secondary to the PR degeneration. Interestingly, a greater RGC number in rd10/S1R−/− versus rd10/S1R+/+ retinas was observed at 3 W, seemingly indicative of RGC protection by S1R knockout. However, unlike rods, from 3 W to 4 W RGCs did not degenerate but rather increased in rd10/S1R+/+ retinas. This suggests that a higher number of RGCs at 3 W in rd10/S1R−/− retinas was not because of faster RGC degeneration in rd10/S1R+/+ retinas. Understanding the exact underlying mechanism awaits future detailed investigation. Nonetheless, the results of RGCs implicate that when designing S1R-targeted interventions to rescue PR cells, a potential impact on RGCs should be taken into consideration.
To date, there is essentially no treatment for RP, which affects more than a million people worldwide by progressive deterioration of vision . While S1R appears to be a promising pathway for intervention to protect cones that are responsible for daylight vision , cone death is caused by dying rods in RP . It is thus important to understand the specific role(s) of S1R at different stages of PR death. Our study reveals a biphasic effect of S1R knockout on rd10 photoreceptors, first boosting rod survival, and then exacerbating apoptosis and rod loss and finally necroptosis and cone death (Fig. 10). This work may inform important implications for future development of S1R-targeted retina-protective therapeutic methods. For example, appropriate timing for delivery of a S1R-activating agent  or its combination with a necroptosis inhibitor , could produce improved therapeutic effects.
We thank Dr. Arnold E. Ruoho for providing S1R knockout mice and Dr. Miles Epstein for consultation on animal breeding.
National Eye Institute grant R01EY022678 and a Morgridge Institute for Research & the James Christenson Estate Macular Degeneration Research Award (to L-WG); NEI R01EY024995 and Retina Research Foundation M. D. Matthews Research Professorship (to BRP); NEI P30EY016665 (to the University of Wisconsin Vision Core); Grant from the Shanghai Key Laboratory of Psychotic Disorders (No.13dz2260500), Shanghai Health Talent Professional Project (XYQ2013114), Shanghai Municipal Commission of Health and Family Planning (No.20124106) and the National Natural Science Foundation of China (No.81371491) to YFu.
Conceiving the research and designing experiments: L-WG, BRP, HY, YF. Performing experiments: HY, YF, XL, PS, TAM, JL, AY, SG. Analyzing data and writing manuscript: HY, YF, BRP, L-WG. Critically reviewing manuscript: L-WG, BRP. All authors read and approved the final manuscript.
All animal procedures conformed to the NIH guide for the ethical care and use of laboratory animals and were in compliance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. Animal protocols were approved by the Institutional Animal Care and Use Committee of University of Wisconsin-Madison and Ohio State University.
Consent for publication
All authors have read the manuscript and indicated consent for publication.
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Hayashi T, Su TP. Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival. Cell. 2007;131:596–610.View ArticlePubMedGoogle Scholar
- Hayashi T. Sigma-1 receptor: the novel intracellular target of neuropsychotherapeutic drugs. J Pharmacol Sci. 2015;127:2–5.View ArticlePubMedGoogle Scholar
- Fontanilla D, Johannessen M, Hajipour AR, Cozzi NV, Jackson MB, Ruoho AE. The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator. Science. 2009;323:934–7.View ArticlePubMedPubMed CentralGoogle Scholar
- Rennekamp AJ, Huang XP, Wang Y, Patel S, Lorello PJ, Cade L, Gonzales AP, Yeh JR, Caldarone BJ, Roth BL, et al. Sigma1 receptor ligands control a switch between passive and active threat responses. Nat Chem Biol. 2016;12:552–8.View ArticlePubMedPubMed CentralGoogle Scholar
- Romero L, Merlos M, Vela JM. Antinociception by Sigma-1 Receptor Antagonists: Central and Peripheral Effects. Adv Pharmacol. 2016;75:179–215.View ArticlePubMedGoogle Scholar
- Maurice T, Su TP. The pharmacology of sigma-1 receptors. Pharmacol Ther. 2009;124:195–206.View ArticlePubMedPubMed CentralGoogle Scholar
- Nguyen L, Lucke-Wold BP, Mookerjee SA, Cavendish JZ, Robson MJ, Scandinaro AL, Matsumoto RR. Role of sigma-1 receptors in neurodegenerative diseases. J Pharmacol Sci. 2015;127:17–29.View ArticlePubMedGoogle Scholar
- Urfer R, Moebius HJ, Skoloudik D, Santamarina E, Sato W, Mita S, Muir KW. Phase II trial of the Sigma-1 receptor agonist cutamesine (SA4503) for recovery enhancement after acute ischemic stroke. Stroke. 2014;45:3304–10.View ArticlePubMedGoogle Scholar
- Francardo V, Bez F, Wieloch T, Nissbrandt H, Ruscher K, Cenci MA. Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism. Brain. 2014;137:1998–2014.View ArticlePubMedGoogle Scholar
- Hedskog L, Pinho CM, Filadi R, Ronnback A, Hertwig L, Wiehager B, Larssen P, Gellhaar S, Sandebring A, Westerlund M, et al. Modulation of the endoplasmic reticulum-mitochondria interface in Alzheimer's disease and related models. Proc Natl Acad Sci U S A. 2013;110:7916–21.View ArticlePubMedPubMed CentralGoogle Scholar
- Ryskamp D, Wu J, Geva M, Kusko R, Grossman I, Hayden M, Bezprozvanny I. The sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse model of Huntington disease. Neurobiol Dis. 2017;97:46–59.View ArticlePubMedGoogle Scholar
- Mavlyutov TA, Epstein ML, Verbny YI, Huerta MS, Zaitoun I, Ziskind-Conhaim L, Ruoho AE. Lack of sigma-1 receptor exacerbates ALS progression in mice. Neuroscience. 2013;240:129–34.View ArticlePubMedPubMed CentralGoogle Scholar
- Al-Saif A, Al-Mohanna F, Bohlega S. A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis. Ann Neurol. 2011;70:913–9.View ArticlePubMedGoogle Scholar
- Luty AA, Kwok JB, Dobson-Stone C, Loy CT, Coupland KG, Karlstrom H, Sobow T, Tchorzewska J, Maruszak A, Barcikowska M, et al. Sigma nonopioid intracellular receptor 1 mutations cause frontotemporal lobar degeneration-motor neuron disease. Ann Neurol. 2010;68:639–49.View ArticlePubMedGoogle Scholar
- Miki Y, Mori F, Kon T, Tanji K, Toyoshima Y, Yoshida M, Sasaki H, Kakita A, Takahashi H, Wakabayashi K. Accumulation of the sigma-1 receptor is common to neuronal nuclear inclusions in various neurodegenerative diseases. Neuropathology. 2014;34:148–58.View ArticlePubMedGoogle Scholar
- Schmidt HR, Zheng S, Gurpinar E, Koehl A, Manglik A, Kruse AC. Crystal structure of the human sigma1 receptor. Nature. 2016;532:527–30.View ArticlePubMedPubMed CentralGoogle Scholar
- Wang J, Cui X, Roon P, Saul A, Smith SB. The Role of Sigma1R in Mammalian Retina. Adv Exp Med Biol. 2017;964:267–84.View ArticlePubMedGoogle Scholar
- Mavlyutov TA, Guo LW. Peeking into Sigma-1 Receptor Functions Through the Retina. Adv Exp Med Biol. 2017;964:285–97.View ArticlePubMedGoogle Scholar
- Smith SB, Duplantier J, Dun Y, Mysona B, Roon P, Martin PM, Ganapathy V. In vivo protection against retinal neurodegeneration by sigma receptor 1 ligand (+)-pentazocine. Invest Ophthalmol Vis Sci. 2008;49:4154–61.View ArticlePubMedPubMed CentralGoogle Scholar
- Zhao L, Chen G, Li J, Fu Y, Mavlyutov TA, Yao A, Nickells RW, Gong S, Guo LW. An intraocular drug delivery system using targeted nanocarriers attenuates retinal ganglion cell degeneration. J Control Release. 2017;247:153–66.View ArticlePubMedGoogle Scholar
- Mavlyutov TA, Nickells RW, Guo LW. Accelerated retinal ganglion cell death in mice deficient in the Sigma-1 receptor. Mol Vis. 2011;17:1034–43.PubMedPubMed CentralGoogle Scholar
- Ha Y, Saul A, Tawfik A, Williams C, Bollinger K, Smith R, Tachikawa M, Zorrilla E, Ganapathy V, Smith SB. Late-onset inner retinal dysfunction in mice lacking sigma receptor 1 (sigmaR1). Invest Ophthalmol Vis Sci. 2011;52:7749–60.View ArticlePubMedPubMed CentralGoogle Scholar
- Wang J, Saul A, Roon P, Smith SB. Activation of the molecular chaperone, sigma 1 receptor, preserves cone function in a murine model of inherited retinal degeneration. Proc Natl Acad Sci U S A. 2016;113:E3764–72.View ArticlePubMedPubMed CentralGoogle Scholar
- Zhao L, Zabel MK, Wang X, Ma W, Shah P, Fariss RN, Qian H, Parkhurst CN, Gan WB, Wong WT. Microglial phagocytosis of living photoreceptors contributes to inherited retinal degeneration. EMBO molecular medicine. 2015;7:1179–97.View ArticlePubMedPubMed CentralGoogle Scholar
- Murakami Y, Matsumoto H, Roh M, Suzuki J, Hisatomi T, Ikeda Y, Miller JW, Vavvas DG. Receptor interacting protein kinase mediates necrotic cone but not rod cell death in a mouse model of inherited degeneration. Proc Natl Acad Sci U S A. 2012;109:14598–603.View ArticlePubMedPubMed CentralGoogle Scholar
- Chang B, Hawes NL, Pardue MT, German AM, Hurd RE, Davisson MT, Nusinowitz S, Rengarajan K, Boyd AP, Sidney SS, et al. Two mouse retinal degenerations caused by missense mutations in the beta-subunit of rod cGMP phosphodiesterase gene. Vis Res. 2007;47:624–33.View ArticlePubMedPubMed CentralGoogle Scholar
- Zhao L, Li J, Fu Y, Zhang M, Wang B, Ouellette J, Shahi PK, Pattnaik BR, Watters JJ, Wong WT, Guo LW. Photoreceptor protection via blockade of BET epigenetic readers in a murine model of inherited retinal degeneration. J Neuroinflammation. 2017;14:14.View ArticlePubMedPubMed CentralGoogle Scholar
- Mavlyutov TA, Epstein M, Guo LW. Subcellular localization of the sigma-1 receptor in retinal neurons - an electron microscopy study. Sci Rep. 2015;5:10689.View ArticlePubMedPubMed CentralGoogle Scholar
- Shi X, Guo LW, Seedial SM, Si Y, Wang B, Takayama T, Suwanabol PA, Ghosh S, DiRenzo D, Liu B, Kent KC. TGF-beta/Smad3 inhibit vascular smooth muscle cell apoptosis through an autocrine signaling mechanism involving VEGF-A. Cell Death Dis. 2014;5:e1317.View ArticlePubMedPubMed CentralGoogle Scholar
- Hannemann L, Suppanz I, Ba Q, MacInnes K, Drepper F, Warscheid B, Koch HG. Redox Activation of the Universally Conserved ATPase YchF by Thioredoxin 1. Antioxid Redox Signal. 2016;24:141–56.View ArticlePubMedPubMed CentralGoogle Scholar
- Pattnaik BR, Shahi PK, Marino MJ, Liu X, York N, Brar S, Chiang J, Pillers DA, Traboulsi EI. A Novel KCNJ13 Nonsense Mutation and Loss of Kir7.1 Channel Function Causes Leber Congenital Amaurosis (LCA16). Hum Mutat. 2015;36:720–7.View ArticlePubMedGoogle Scholar
- Zhao J, Ha Y, Liou GI, Gonsalvez GB, Smith SB, Bollinger KE. Sigma receptor ligand, (+)-pentazocine, suppresses inflammatory responses of retinal microglia. Invest Ophthalmol Vis Sci. 2014;55:3375–84.View ArticlePubMedPubMed CentralGoogle Scholar
- Wang J, Shanmugam A, Markand S, Zorrilla E, Ganapathy V, Smith SB. Sigma 1 receptor regulates the oxidative stress response in primary retinal Muller glial cells via NRF2 signaling and system xc(−), the Na(+)-independent glutamate-cystine exchanger. Free Radic Biol Med. 2015;86:25–36.View ArticlePubMedPubMed CentralGoogle Scholar
- Vollrath JT, Sechi A, Dreser A, Katona I, Wiemuth D, Vervoorts J, Dohmen M, Chandrasekar A, Prause J, Brauers E, et al. Loss of function of the ALS protein SigR1 leads to ER pathology associated with defective autophagy and lipid raft disturbances. Cell Death Dis. 2014;5:e1290.View ArticlePubMedPubMed CentralGoogle Scholar
- Schrock JM, Spino CM, Longen CG, Stabler SM, Marino JC, Pasternak GW, Kim FJ. Sequential cytoprotective responses to Sigma1 ligand-induced endoplasmic reticulum stress. Mol Pharmacol. 2013;84:751–62.View ArticlePubMedPubMed CentralGoogle Scholar
- Ha Y, Dun Y, Thangaraju M, Duplantier J, Dong Z, Liu K, Ganapathy V, Smith SB. Sigma receptor 1 modulates endoplasmic reticulum stress in retinal neurons. Invest Ophthalmol Vis Sci. 2011;52:527–40.View ArticlePubMedPubMed CentralGoogle Scholar
- Hanus J, Zhang H, Wang Z, Liu Q, Zhou Q, Wang S. Induction of necrotic cell death by oxidative stress in retinal pigment epithelial cells. Cell Death Dis. 2013;4:e965.View ArticlePubMedPubMed CentralGoogle Scholar
- Sato K, Li S, Gordon WC, He J, Liou GI, Hill JM, Travis GH, Bazan NG, Jin M. Receptor interacting protein kinase-mediated necrosis contributes to cone and rod photoreceptor degeneration in the retina lacking interphotoreceptor retinoid-binding protein. J Neurosci. 2013;33:17458–68.View ArticlePubMedPubMed CentralGoogle Scholar
- Rodriguez-Muela N, Hernandez-Pinto AM, Serrano-Puebla A, Garcia-Ledo L, Latorre SH, de la Rosa EJ, Boya P. Lysosomal membrane permeabilization and autophagy blockade contribute to photoreceptor cell death in a mouse model of retinitis pigmentosa. Cell Death Differ. 2015;22:476–87.View ArticlePubMedGoogle Scholar
- Oyadomari S, Mori M. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ. 2004;11:381–9.View ArticlePubMedGoogle Scholar
- Sano R, Reed JC. ER stress-induced cell death mechanisms. Biochim Biophys Acta. 1833;2013:3460–70.Google Scholar
- Mavlyutov TA, Yang H, Epstein ML, Ruoho AE, Yang J, Guo LW. APEX2-enhanced electron microscopy distinguishes sigma-1 receptor localization in the nucleoplasmic reticulum. Oncotarget. 2017;8:51317–30.Google Scholar